Cargando…
Sex Differences in Platelet Reactivity in Patients With ST-Elevation Myocardial Infarction: A Sub-Analysis of the ON-TIME 3 Trial
Background: Fast and adequate platelet inhibition is one of the cornerstones in the treatment of patients with ST-elevation myocardial infarction (STEMI). The aim of this analysis is to examine sex differences in platelet inhibition in the acute treatment of STEMI patients. Methods: Platelet reactiv...
Autores principales: | Tavenier, Anne H., Hermanides, Renicus S., Ottervanger, Jan Paul, Belitser, Svetlana V., Klungel, Olaf H., Appelman, Yolande, van Leeuwen, Maarten A.H., van 't Hof, Arnoud W.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520931/ https://www.ncbi.nlm.nih.gov/pubmed/34671649 http://dx.doi.org/10.3389/fcvm.2021.707814 |
Ejemplares similares
-
Impact of opioids on P2Y(12) receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial
por: Tavenier, Anne H, et al.
Publicado: (2020) -
Current and Future Insights for Optimizing Antithrombotic Therapy to Reduce the Burden of Cardiovascular Ischemic Events in Patients with Acute Coronary Syndrome
por: Selvarajah, Abi, et al.
Publicado: (2022) -
Large anterolateral ST-elevation myocardial infarction in a patient with an isolated type R-I single coronary artery: a case report
por: Duijvelshoff, Renee, et al.
Publicado: (2021) -
Randomised comparison of drug-eluting versus bare-metal stenting in patients with non-ST elevation myocardial infarction
por: Remkes, Wouter S, et al.
Publicado: (2016) -
A randomised, investigator-initiated, clinical trial of the effects of fentanyl on P2Y12-receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: rationale and design of the Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial
por: Tavenier, A. H., et al.
Publicado: (2019)